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Abstract
Salmonella enterica subspecies 1 serovar Typhimurium (S. Typhimurium) causes diarrhea and acute inflammation of the
intestinal mucosa. The pro-inflammatory cytokines IL-17A and IL-17F are strongly induced in the infected mucosa but their
contribution in driving the tissue inflammation is not understood. We have used the streptomycin mouse model to analyze
the role of IL-17A and IL-17F and their cognate receptor IL-17RA in S. Typhimurium enterocolitis. Neutralization of IL-17A
and IL-17F did not affect mucosal inflammation triggered by infection or spread of S. Typhimurium to systemic sites by 48 h
p.i. Similarly, Il17ra
2/2 mice did not display any reduction in infection or inflammation by 12 h p.i. The same results were
obtained using S. Typhimurium variants infecting via the TTSS1 type III secretion system, the TTSS1 effector SipA or the
TTSS1 effector SopE. Moreover, the expression pattern of 45 genes encoding chemokines/cytokines (including CXCL1,
CXCL2, IL-17A, IL-17F, IL-1a, IL-1b, IFNc, CXCL-10, CXCL-9, IL-6, CCL3, CCL4) and antibacterial molecules was not affected by
Il17ra deficiency by 12 h p.i. Thus, in spite of the strong increase in Il17a/Il17f mRNA in the infected mucosa, IL-17RA
signaling seems to be dispensable for eliciting the acute disease. Future work will have to address whether this is
attributable to redundancy in the cytokine signaling network.
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Introduction
S. Typhimurium is a Gram-negative enteropathogen and a
frequent cause of diarrhea. After ingestion, the bacteria travel
through the alimentary tract, manipulate cells of the intestinal
mucosa and thereby elicit the disease which is characterized by
fluid accumulation in the gut lumen and gut tissue inflammation.
We are just beginning to understand the complex molecular
interplay between the pathogen and the host which leads to
disease.
S. Typhimurium induced gut inflammation has been studied in
bovine, murine and primate animal models. In all three models, it
involves epithelial damage and PMN influx and similar chemo-
kine/cytokine induction profiles. This includes the chemokines/
cytokines CXCL1, CXCL2, IL-1a, IL-1b, IFNc, IL-17A, IL-17F,
CXCL-10, CXCL-9, IL-6, CCL3, CCL4 some of which are
strong phagocyte chemo-attractants, as well as molecules impli-
cated in anti-microbial defense like Nos2, lipocalin 2 and
antimicrobial peptides ([1,2,3], own unpublished data). This
similarity implies that the molecular mechanisms driving the
disease are equivalent in all three animal models.
So far, the detailed mechanism for the induction of mucosal
inflammation by Salmonella spp. remains unclear. Most likely,
initial signals are produced by the few cells of the mucosa which
become directly infected as well as by recognition of microbe
associated molecular patterns (MAMP; e.g. lipidA, flagellin)
released by the invading pathogen [4,5,6,7,8,9,10]. Several lines
of evidence imply a key role for IL-17 signaling in S. Typhimurium
diarrhea. a) IL-17 signaling is implicated in several cases of
mucosal infection or inflammation, i.e. Klebsiella pneumoniae lung
infections [11,12], Mycoplasma pneumoniae infection [13], allergic
airway inflammation [14], Helicobacter hepaticus colitis [15] and
DSS-induced colitis [16]. Furthermore, segmented filamentous
bacteria (SFB) induce a Th17 response that acts protective against
intestinal pathogen Citrobacter rodentium [17]. Thus, by analogy IL-
17 signaling might also contribute to mucosal S. Typhimurium
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13804infection. b) IL-17A and IL-17F are strongly induced in the
Salmonella-infected gut ([1,18,19,20], own unpublished data).
Il17ra, which encodes a key subunit of a receptor binding IL-
17A and IL-17F, is expressed on many cell types including cells of
the intestinal mucosa (reviewed in [21]). c) S. Typhimurium-
induced gut inflammation was attenuated in Il17ra
2/2 mice by
day 2 post infection [19]. However, the specific roles of IL-17A
and IL-17F and their downstream targets in S. Typhimurium-
induced mucosal inflammation have remained poorly defined.
S. Typhimurium expresses multiple virulence factors capable
of eliciting gut inflammation. The type III secretion systems
encoded in Salmonella pathogenicity islands-1 and -2 (termed
TTSS1 and TTSS2 in this paper) are prominent factors [10,22].
TTSS1 triggers the inflammation during the first day of infection
even in the absence of TTSS2 [23], while TTSS2 contributes to
mucosal disease at later time points [10,22]. To characterize the
contribution of TTSS1 to inflammation during the first hours of
infection and to exclude any potential influence of TTSS2, one
can use the mutant S.Tm* which lacks TTSS2 (SL1344,
sseD::aphT; [10,22]). Similarly, the respective contribution of
the TTSS1 ‘‘effector proteins’’ SipA and SopE can be studied
using appropriate site directed mutants: SipA-dependent cas-
pase-1 independent inflammation, using S.Tm
SipA (SL1344,
sseD::aphT sopE sopB sopE2; [9,10]) and SopE-dependent
caspase-1 dependent inflammation using S.Tm
SopE (SL1344,
sseD::aphT sipA sopB sopE2; [9,10]). Strains lacking TTSS1 and
TTSS2 (S.Tm
avir;S L 1 3 4 4DinvG sseD::aphT; [24]) do not elicit
gut inflammation. These strains should provide sensitive tools for
studying how IL-17 responses are triggered and how they drive
the disease.
In this manuscript, we have studied the role of IL-17A and IL-
17F-signaling in the initial phase of the Salmonella gut infection. We
analyzed the effects of IL-17A or -F neutralization and compared
disease pathology and cytokine profiles elicited in wt mice and
isogenic Il17ra
2/2 littermates. Gut inflammation and pronounced
cytokine induction was observed in all animals infected with
virulent S. Typhimurium strains. However, neither disease
pathology nor cytokine induction profiles were affected by
cytokine neutralization or Il17ra deficiency by 12 h p.i.. Thus,
IL-17A and IL-17F signaling does not seem to affect the initial
phase of acute mucosal disease.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee (Kantonales Veterina ¨ramt Zu ¨rich, Zu ¨rich
Switzerland, licence number 201/2007).
Mice
All mice were bred and kept specified pathogen free in
individually ventilated cages (RCHCI, ETH Zu ¨rich and Biosup-
port, Schlieren). Il17ra
2/2 mice (C57BL/6 N5 backcross) ([25]; 5
generations in C57BL/6 background) were kindly provided by
Amgen and backcrossed for one more generation onto C57BL/6
(Charles River). Mice were genotyped by PCR using the following
oligonucleotides: KS35.20: AGCTGCTGTTAGCACTTTGC;
TGX53.18: CTTGTGTAGCGCCAAGTG; KS37.19: CGTAC-
GCACACACTCTCGA. Il17ra
+/2 and Il17ra
2/2 (C57BL/6 N6
backcross) littermates were used for experiments together with
C57BL/6 mice from our colony as positive controls. Mice of all
groups were sex and age matched (8–10 weeks old).
Mice were pretreated with streptomycin (1 dose, 20 mg/animal,
by gavage) and infected with 5610
7 cfu by gavage 24 h later
[26,27]. Live bacterial loads (colony forming units, cfu) in
mesenteric lymph nodes (mLN), spleen and the cecal content
were determined by plating [27].
Bacterial strains
All S. Typhimurium strains are isogenic derivatives of SL1344
[28]. S.Tm* (SL1344, sseD::aphT; M556), S.Tm
SipA (SL1344,
sseD::aphT sopE sopB sopE2; M716), S.Tm
SopE (SL1344, sseD::aphT
sipA sopB sopE2; M717) and S.Tm
avir (SL1344, DinvG sseD::aphT;
M557) have been described, recently [9,24]. The strains were
grown for 12 h at 37uC in LB (0.3 M NaCl) and sub-cultivated for
4 h as described [24].
Histopathology
HE-stained cecum cryosections were scored as described,
evaluating submucosal edema, PMN infiltration, goblet cells and
epithelial damage yielding a total score of 0–13 points [26].
Vaccination of mice using IL-17A-VLP and IL-17F-VLP
VLP-based IL-17 vaccines were generated as described recently
[29]. Briefly, murine IL-17A (aa 26–158) and murine IL-17F (aa
29–161) flanked by an N-terminal hexa-histidine tag and a C-
terminal linker sequence consisting of five glycine residues and one
cysteine residue were recombinantly expressed in E.coli strain
BL21. Purified and refolded cytokines were then covalently linked
to VLPs of the bacteriophage Qb using the heterobifunctional
crosslinker SMPH as described [29], resulting in VLPs displaying
either the cytokine IL-17A (IL-17A-VLPs) or the cytokine IL-17F
(IL-17F-VLPs).
Mice were immunized thrice in 10 day intervals by s.c. injection
of 50 mg of either VLPs alone, IL-17A-VLPs, IL-17F-VLPs or a
mixture of both. Two weeks after the last immunization sera of
immunized mice were analyzed for presence of aIL-17A or aIL-
17F IgGs by ELISA as described previously.
Quantitative RT-PCR
The cecum tissue was excised, washed in cold PBS, placed in
600 ml RNAlater-buffer (RNeasy Mini Kit, Qiagen), stored for 2 h
on 4uC and subsequently frozen. Total RNA was extracted using a
Nucleospin RNA II kit (Macherey Nagel, Germany) and reverse-
transcribed using the High-Capacity cDNA Archive Kit (Applied
Biosystems, USA). The resulting cDNA was amplified using
TaqMan assays in the Taqman Low Density Array (TLDA)
format (Applied Biosystems). Analysis was carried out using Real
Time StatMiner software from Integromics. Relative mRNA levels
(2
2DDCt) were determined by comparing (a) the PCR cycle
thresholds (Ct) for 45 genes of interest and the 3–4 house-keeping
genes 18S, Actb, and Gapdh (or B2m)( DCt) and (b) DCt values for
treated and control groups (DDCt). In all experiments, Ct upper
limit was fixed to 33 cycles.
For analysis of Il17ra expression, RNA was processed using the
RNeasy mini kit (Qiagen), the RNase-Free DNase kit (Qiagen), M-
MLV reverse Transcriptase RNase H Minus (Promega) and
RNasin (Promega). qPCR analysis of Il17ra (59- AGTGTTT-
CCTCTACCCAGCAC-39 and 59-GAAAACCGCCACCGCT-
TAC-39)[30] and GAPDH (59-GGCTGCCCAGAACATCATC-
CCTGCAT-39 and 59-ACGTCAGATCCACGACGGACACA-
TTGG-39) was performed using the SensiMix Plus SYBR Green
kit (Peqlab Biotechnologie GMBH, Germany). Relative mRNA
levels (2
2DDCt) were determined by comparing (a) the PCR cycle
thresholds (Ct) for Il17ra and Gapdh (DCt) and (b) DCt values for
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e13804Figure 1. Effect of IL-17A and/or F immunization on the S.Typhimurium infection. C57BL/6 mice were vaccinated three times (50 mg each,
s.c.) with IL-17A-VLP, IL-17F-VLP, either reagents or unconjugated control VLPs. A–C) aIL-17A and aIL-17F titers were analyzed two weeks after the last
immunization by ELISA and compared to unconjugated-VLP immunized controls (B,C; OD450 nm values +/2 SEM). D,E) Neutralization was tested by
ELISA. D) ELISA plates were coated with 1 mg/ml IL-17RA and binding of 10 ng/ml biotinylated IL-17A to IL-17RA was tested in the presence of serum
of mice immunized with IL-17A-VLPs, IL-17F-VLPs or VLPs alone (OD450 nm values +/2 SEM). E) ELISA plates were coated with 1 mg/ml IL-17RC and
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e13804treated and control groups (DDCt). The Ct upper limit was fixed to
33 cycles. Cycling parameters were 94uC (15 s), 60uC (30 s), 72uC
(30 s) in a RotorGene 3000 cycler (Corbett Research, Cambridge-
shire, UK).
Statistical analysis
Statistical analysis of the animal experiments was performed
using the exact Mann-Whitney U test. To perform statistical
analysis, minimal detectable bacterial colonization levels (CFU)
were set to 10 CFU/mLN, 20 CFU/spleen, 60 CFU/liver,
10 CFU/g cecum content, in cases where no bacteria were
detected by plating. A P value of ,0.05 (two tailed) was considered
to be statistically significant.
The Limma test with Bonferroni multiple hypothesis testing was
used for high throughput PCR analyses with Taqman Low Density
Arrays. For the RT-PCR analysis of the Il17ra expression in the
cecum,the unpairedt-test (two-tailed) hasbeenused. Cecal pathology
of cytokine vaccinated mice has been analyzed by the exact Mann-
Whitney U test as well as ANOVA with Bonferroni post test.
Results
Antibody-mediated neutralization of IL-17A and IL-17F
did not affect S. Typhimurium enterocolitis
First, we employed a neutralization strategy to analyze the
contribution of IL-17A and/or IL-17F in S. Typhimurium
enterocolitis. We neutralized endogenous IL-17A and IL-17F by
vaccination of C57BL/6 mice with virus-like particles coupled to
murine IL-17A (IL-17A-VLP) or IL-17F (IL-17F-VLP) proteins as
described previously [29,31]. This earlier work had established that
IL-17 cytokine vaccination is capable of alleviating IL-17 driven
disease in two different models of chronic inflammatory disease in
vivo. The IL-17A-VLP/IL-17F-VLP vaccination strategy is of
advantage, as it avoids possible artefacts attributable to ontogenetic
defects in immune system maturation which may be observed in
knockout mice. In addition, all mice come from the same colony
which circumvents any variations emanating from microbiota
composition which may affect the results of the infection
experiments (Stecher and Hardt, unpublished observation).
C57BL/6 mice (n=5 mice per group) were vaccinated with
either IL-17A-VLP, IL-17F-VLP, both reagents or unconjugated
control VLPs (Materials and Methods). Two weeks after immuni-
zation, aIL-17A and aIL-17F serum IgG responses were verified by
ELISA (Fig. 1A–C) and by inhibiting the binding of IL-17A to IL-
17RA or IL-17F to IL-17RC (Fig. 1D,E). Then, the mice were
pretreated with streptomycin and infected by gavage with wild type
S. Typhimurium (S.Tm, 5*10
7 cfu). Bacterial loads in the gut
lumen, mLNs, spleens and livers showed no significant differences
comparingnon-vaccinated and vaccinated mice(p$0.05; Fig. 1F–I)
two days post infection. Moreover, histopathological analysis
revealed comparable inflammation of the cecum mucosa (p$0.05;
Fig. 1J). These results demonstrated that neutralization of IL-17A
and/or IL-17F did not affect the course of Salmonella enterocolitis
during the first two days of infection in the streptomycin mouse
model. Similar results were obtained in IL-17A knockout mice
infected with wildtype S. Tm (data not shown).
Taken together, these results suggested that IL-17A and IL-17F
may play a limited (if any) role in S. Typhimurium-induced gut
inflammation.
Il17ra
2/2 mice showed normal levels of S.Typhimurium-
induced gut inflammation at 12 h p.i.
In a second series of experiments, to assess the roles of IL-17A
and IL-17F in Salmonella enterocolitis, we studied mice lacking
IL-17RA, which binds both IL-17A and IL-17F. Il17ra
2/2
(C57BL/6 N6; [25]) and control Il17ra
+/2 littermates or
C57BL/6 wild-type mice were infected with S.Tm* or isogenic
derivatives thereof, i.e. S.Tm
SipA, S.Tm
SopE or S.Tm
avir (Materials
and Methods). S.Tm* is known to elicit profound gut inflamma-
tion via TTSS1 which is equivalent to that by wt S. Typhimurium,
but eliminates any possible contributions of TTSS2 [9,23,24,32].
Therefore, S.Tm* should provide a more sensitive readout than wt
S.Tm for any effects of IL-17RA on Salmonella enterocolitis.
S.Tm
SipA and S.Tm
SopE rely on SipA or SopE respectively for
eliciting inflammation [9,24]. This may reduce redundancy in the
pro-inflammatory signaling pathways and should reveal even very
subtle susceptibility phenotypes of the knockout mice. The control
strain S.Tm
avir does not elicit gut inflammation [10]. All animals
were pretreated with streptomycin and infected for 12 h with
5610
7 cfu (by gavage; n=3–7 mice per group) of the indicated
strain. By 12 h post infection, wild type mice have already
mounted gut inflammation (Songhet, Barthel, Hardt, unpub-
lished). Any delays in mounting gut inflammation in the knockout
mice should be detectable with high sensitivity at this time point.
After 12 h, the animals were sacrificed, the pathogen loads in the
cecum lumen, the mLN and the spleens were analyzed and we
removed cecum tissue samples for histopathological analysis and
for RNA extraction.
All bacterial strains efficiently colonized the cecum lumen in all
mice analyzed (Fig. 2A). Spread to mLN was not significantly
affected in any of the groups, indicating that dissemination to
deeper sites of the GALT was not affected in the Il17ra
2/2 mice at
this early stage of the infection (p$0.05; Fig. 2B). Moreover, we
did not detect spread to spleens and livers in the Il17ra
2/2 (data
not shown). However, as these systemic sites are normally not
colonized by the pathogen at these early time points, we cannot
draw conclusions about the role of IL-17RA-deficiency in systemic
pathogen spread.
As expected, S.Tm*, S.Tm
SipA and S.Tm
SopE triggered overt
inflammation in the cecal mucosa of the IL-17A/F-signaling
proficient Il17ra
+/2 littermates and the wt C57BL/6 control mice
(Fig. 2C, Fig. 3). Surprisingly, S.Tm*, S.Tm
SipA and S.Tm
SopE
triggered equivalent levels of gut inflammation in the Il17ra
2/2
and in the Il17ra
+/2 littermates (p$0.05; Fig. 2C, Fig. 3). Thus,
IL-17RA signaling was dispensable for mounting mucosal
inflammation by 12h p.i..
Cytokine profiles were not altered in the cecum tissue of
S.Typhimurium-infected Il17ra
2/2 mice at 12 h p.i.
In order to analyze how Il17ra deficiency affected early immune
responses, we have performed quantitative RT-PCR analysis using
Taqman Low Density Arrays on cecum tissue samples from
binding of 200 ng/ml biotinylated IL-17F to IL-17RC was tested in the presence of serum of mice immunized with IL-17A-VLPs, IL-17F-VLPs or VLPs
alone; OD450 nm values +/2 SEM. F–J) Subsequent analysis in S. Typhimurium challenge infections. Animals were pretreated with streptomycin and
infected for 2 days with wt S. Typhimurium. PBS immunization and PBS treatment served as control. We analyzed colonization levels in the gut lumen
(F), the mLN (G), the liver (H) and the spleen (I), as well as the degree of inflammation of the cecum mucosa (J). Comparison with the control VLPs
immunized mice did not reveal any significant differences in any of the parameters of the infection, analyzed (J: Mann-Whitney U test was not
significant as well as ANOVA with Bonferroni (p=0.0841)). Stippled line: minimal detectable value.
doi:10.1371/journal.pone.0013804.g001
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2/2 mice. Il17ra
2/2 mice, Il17ra
+/2 littermates and C57BL/6 control mice were pretreated with
streptomycin and infected for 12 hours with S.Tm* or isogenic derivatives S.Tm
SipA, S.Tm
SopE, S.Tm
avir (Material and Methods). We analyzed
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2/2, Il17ra
+/2 and C57BL/6 mice. We determined the
relative mRNA levels for a set of 45 genes encoding immune
mediators, including IL-17A and IL-17F, as well as IL-22,
CXCL1, CXCL2, IL-23 p19, IL-12 p40, IFNc and TNFa. First,
we found that steady-state levels of mRNA are similar in C57BL/6
and the IL-17RA-deficient mice (Fig. 4A). In line with previous
work on a later stage of the infection (day 2 p.i.; [1,18,19]; own
unpublished data), S.Tm* dramatically induced the expression of
Il17a and Il17f as well as a large array of pro-inflammatory
cytokines and innate defense molecules already by 12 h p.i.
(Fig. 4B, grey bars; incl. antimicrobial peptides RegIIIb, Reg3c,
S100A9, inducible nitric oxide synthase, or the pattern recognition
pentraxin PTX3). This also included several genes known to be
regulated or co-regulated by IL-17 cytokines (CXCL1, CXCL2,
CXCL5, CCL2, CCL7 and S100A9; [2,33]). Surprisingly, the
gene expression profiles of the S.Tm* infected Il17ra
2/2 mice did
not differ significantly from those of Il17ra
+/2 littermates or the wt
C57BL/6 controls, including CXCL1, CXCL2, CXCL5, CCL2,
CCL7 and S100A9 (p$0.05 for all cytokines; Il17ra
2/2 vs.
Il17ra
+/2; Fig. 4B). The same was observed for the mice infected
with either S.Tm
SipA or S.Tm
SopE (Fig. 5A,B). Slightly altered
expression of two genes in S.Tm
SipA infected mice was the only
exception (Gem, Nos2; p,0.05; Fig. 5A). Future work will have to
address the reasons for this. Nevertheless, overall these data
demonstrated that IL-17RA deficiency did not affect inflammatory
pathology and mucosal chemokine/cytokine induction at 12 h
post infection.
Il17ra is expressed by the intestinal mucosa
Finally, we have verified that Il17ra is indeed expressed in the
gut. For this purpose, we recovered tissue samples from the
duodenum, jejunum, ileum, cecum and colon of naı ¨ve C57BL/6
mice and analyzed Il17ra mRNA levels by real time PCR. Il17a
and Il17f served as controls. These data verified that the Il17ra
gene is expressed to detectable levels in all parts of the naı ¨ve gut
(Fig. 6A). In a second approach, we analyzed Il17ra induction
during infection. 12 hours after infection with S.Tm*, the Il17ra
expression in cecum tissues was slightly, but significantly higher
than in streptomycin pretreated non-infected controls (Fig. 6B).
Thus, Il17ra is clearly expressed in the naı ¨ve and in the infected
intestinal mucosa.
Discussion
Salmonella diarrhea involves the elicitation of acute mucosal
inflammation within 6–10 h post infection. The acute mucosal
response includes the transcriptional up-regulation of more than
100 genes encoding pro-inflammatory cytokines, antimicrobial
defenses and cytokines initiating adaptive immune responses
[1,18,19,20]. It is assumed that initial signals emanate from those
Figure 3. Mucosal inflammation in S.Typhimurium infected Il17ra
2/2 mice. Cryosections of Il17ra
+/2, Il17ra
2/2 and C57BL/6 mice infected
with S.Tm*, S.Tm
SipA and S.Tm
SopE for 12hpi were stained with HE. Representative animals were chosen from the experiment shown in Fig. 2.
Bar =100 mm.
doi:10.1371/journal.pone.0013804.g003
colonization levels in the gut lumen (A) and the mLN (B), as well as the degree of inflammation of the cecum mucosa (C). n.s.: No significant difference
between Il17ra
2/2 mice and Il17ra
+/2 littermates. Strippled line: minimal detectable value.
doi:10.1371/journal.pone.0013804.g002
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infection, and that these initial signals are amplified subsequently
in order to mount a tissue-wide defense. The induced genes have
been identified, but their role in the disease process has remained
poorly defined. Here, we have analyzed the role of IL-17 signaling.
Levels of IL-17A and IL-17F encoding mRNA are strongly
elevated in the S. Typhimurium infected cecum mucosa [1,19].
We found that cytokine-neutralization of IL-17A and/or F or a
genetic IL-17RA-deficiency did not affect S. Typhimurium colitis,
i.e. pathogen colonization of the mLN, degree of intestinal
inflammation and the patterns of cytokines induced by 12 h p.i.
Earlier work had assessed the role of IL-17 signaling at day 2 p.i.
with S. Typhimurium 14028 [19]. This publication had employed
the same streptomycin mouse model [26] as we have used in our
study and found that Il17ra
2/2 mice failed to mount an efficient
mucosal response (i.e. neutrophil influx, KC/CXCL1 induction)
and had an increased susceptibility to systemic spread of the
pathogen by day 2 p.i. [19]. This may suggest that IL-17 signalling
Figure 4. Cytokine expression profile of S.Tm
*-infected Il17ra
+/2, Il17ra
2/2and C57BL/6 mice. Salmonella-infected animals (n=3) from
experiment shown in Fig. 2 were used for analysis of gene expression signature. Cecum samples from Il17ra
2/2, Il17ra
+/2, and C57BL/6 mice 12 h p.i.
with S.Tm*, S.Tm
SipA or S.Tm
SopE, were taken for RNA isolation and RT-PCR (B–D). C57BL/6 mice, only treated with streptomycin, were used as a
control, not differing significantly from Il17ra
2/2 (A). 45 genes related to inflammation and defense, especially in IL-17-mediated responses were
used. The analysis was performed using RealTime StatMiner Software; mRNA levels were normalized to 3 house-keeping genes: Actb, Gapdh and 18S
(DCt). Relative quantification was determined by the DDCt method after normalization to streptomycin-treated C57BL/6 animals. Statistical analysis
was done using the Limma test with Bonferroni correction (B). All results for S.Tm
*-infection did not differ significantly between Il17ra
2/2 and
Il17ra
+/2 mice (p$0.05).
doi:10.1371/journal.pone.0013804.g004
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our IL-17A-VLP/IL-17F-VLP vaccinated mice were analysed at day
2 p.i.. In this experimental system, we did not observe disease
phenotypes attributable to the anti-cytokine vaccination. However,
we could not precisely control the degree of functional IL-17 cytokine
neutralization within the gut tissues of the infected animals.
Therefore, the lack of significant effects on gut pathology might be
attributable to incomplete neutralization. Nevertheless, our data on
IL-17 cytokine neutralization is of significant interest for assessing the
possible side effects (i.e. increased pathogen susceptibility) of
immunodrugs neutralizing IL-17 responses.
It was interesting to note that IL-17A and IL-17F and several
genes known to be regulated by IL-17, e.g. CXCL1, CXCL2,
CXCL5, CCL2, CCL7 and S100A9, were highly induced in the S.
Typhimurium infected cecum mucosa, but that IL-17RA
deficiency did not affect cytokine expression (Fig. 4). Several
different explanations might account for this. i) A possible lack of
IL-17RA expression in the cecum mucosa. This does not seem
likely, as IL-17RA is expressed ubiquitously [30,34]. This was
verified for the duodenum, jejunum, ileum,cecum and colon
tissues of naı ¨ve mice (Fig. 6A). In the inflamed cecum, Il17ra
expression was even more pronounced (Fig. 6B). Furthermore, the
Figure 5. Cytokine expression profile of S.Tm
SipA- and S.Tm
SopE-infected Il17ra
+/2, Il17ra
2/2 and C57BL/6 mice. Salmonella-infected
animals (n=3) from experiment shown in Fig. 2 were used for analysis of gene expression signature. Cecum samples from Il17ra
2/2, Il17ra
+/2, and
C57BL/6 mice 12 h p.i. with S.Tm
SipA or S.Tm
SopE, were taken for RNA isolation and RT-PCR (A–B). 45 genes related to inflammation and defense,
especially in IL-17-mediated responses were used. The analysis was performed using RealTime StatMiner Software; mRNA levels were normalized to 3
house-keeping genes: Actb, Gapdh and 18S (DCt). Relative quantification was determined by the DDCt method after normalization to streptomycin-
treated C57BL/6 animals. Statistical analysis was done using the Limma test with Bonferroni correction (A–B). All results presented in panels A and B
did not differ significantly between Il17ra
2/2 and Il17ra
+/2 mice (p$0.05) with the exception of Gem and Nos2 in panel A (*: p,0.05).
doi:10.1371/journal.pone.0013804.g005
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pathology of DSS-induced colitis [16] and IL-17A and -F are
known to induce enterocyte expression of antimicrobial peptides
and numerous pro-inflammatory cytokines. Thus, lack of Il17ra
expression cannot account for our failure to detect a virulence
phenotype in the gut mucosa of Il17ra
2/2 mice. ii) Insufficient
levels of IL-17A/F induction. It is known that IL-17A and IL-17F
differ significantly in terms of their threshold concentration
required for inducing IL-17RA-mediated responses
[30,35,36,37]. The cytokine threshold concentration for IL-
17RA responses in the cecum tissue is not known. Our data
suggests that the IL-17A and -F levels in the cecum mucosa might
simply not reach the required levels for inducing mucosal IL-
17RA responses. On the other hand, the IL-17A/F induction was
as pronounced as reported earlier for day 2 p.i. [1,18]. iii) Timing
of responses. One might argue that the 12 h p.i. time point might
not allow sufficient time for IL-17 induced responses (Fig. 4 and 5).
However, the expression analysis included several host genes
known to be regulated by IL-17, e.g. CXCL1, CXCL2, CXCL5,
CCL2, CCL7 and S100A9. All of them were strongly induced in
the cecum mucosa at 12 h p.i. IL-17RA-deficiency did not
significantly affect these responses. Thus, the expression of these
genes does not require IL-17 signaling at 12 h p.i.. This does not
exclude that IL-17 signals might contribute to sustained pro-
inflammatory gene expression at later stages of the infection (day 2
p.i. [19]). iv) Cytokine redundancy. During infection IL-17A, can
induce multiple pro-inflammatory cytokines, chemokines and
antimicrobial effectors (reviewed in [33]). However, many other
cytokines can do so, too and multiple signals, including IL-22 and
IFNc [19,20], will drive tissue inflammation in a redundant
fashion during the course of a real infection. Thus, disrupting just
one of these cytokine-signaling pathways, as in Il17ra
2/2 mice,
may not be sufficient for blunting the tissue-wide response. v.
Receptor redundancy. Our study focused on IL-17RA and its
ligands IL-17A and IL-17F. However, some studies suggest that
IL-17RC homodimers can also bind and respond to IL-17F
[30,38]. Our IL-17F-neutralization experiments suggest that this
type of IL-17F to IL-17RC signaling does not contribute
significantly to mucosal inflammation. However, formally we
cannot rule out that this signaling may contribute in some way.
Future work will have to address these hypotheses.
We cannot exclude that IL-17A and -F may have important
functions (besides acute mucosal responses) for immunity and
defense. For example, these IL-17 cytokines may initiate adaptive
immune responses or granulopoiesis in the bone marrow. These
phenotypes have not been analyzed in the present study and would
be an interesting topic for future research.
In conclusion, we found that deficiency in IL-17A or IL-17F
signaling did not affect the initial phase of acute Salmonella
enterocolitis in the streptomycin mouse model. This may indicate
that the cytokine network eliciting mucosal inflammation in
response to the S. Typhimurium infection is highly redundant or
that other cytokines might be more important drivers of
inflammation. Indeed, recent work has implicated a key role of
caspase-1-mediated IL-1 and IL-18 responses in mucosal inflam-
mation elicited by SopE [9]. However, this work also demonstrat-
ed that additional cytokines must be involved in the response to
the wild type pathogen. Identifying these responses will be an
important task for future work and is the key for the mechanistic
understanding of the disease and for identifying novel targets for
cure and/or prevention of the disease.
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Figure 6. Il17ra expression in the gut of control and S.Tm
*-infected C57BL/6 mice. (A) Il17a, Il17f and Il17ra expression in the intestinal
tissues of naı ¨ve mice (n=3 per group). Relative levels of mRNA in 20 ng total RNA were normalized to house keeping genes. DCt values do not strictly
correlate to the difference in gene expression between various genes. However, DCt values ,19 represent detectable levels of expression,
demonstrating thereby that all three genes are expressed in the various tissue segments. (B) Induction of Il17ra expression in Salmonella-infected
animals. Salmonella-infected animals (n=3; 12 h p.i. with S.Tm*; open circles) were from the experiment shown in Fig. 2. Non-infected, stereptomycin
pretreated C57BL/6 mice (n=3; black circles) served as a contol. Samples of gut tissues (A, as indicated; B, cecum tissue) were taken for RNA isolation
and mRNA levels were analyzed by real time PCR. S.Tm
* infected C57BL/6 mice showed a significant up-regulation of Il17ra in comparision to non-
infected C57BL/6 mice (p,0.05; t-test unpaired, two-tailed). Sm: Streptomycin. Line: median.
doi:10.1371/journal.pone.0013804.g006
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